Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of the wildly popular drug.
The Food and Drug Administration (FDA) on Friday declared shortages of three intravenous drugs produced at a North Carolina ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
The FDA's drug shortage staff already works with ... Before recently, Finley paid little attention to drug shortages, never imagining that critical drugs such as the carboplatin she relied on ...